Werewolf Therapeutics, Inc. (NASDAQ: HOWL) reported Q1 EPS of ($0.28), $0.01 worse than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Werewolf Therapeutics, Inc. (HOWL) click here.